A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality.
Experimental and Clinical Psychopharmacology · 2024-06 · 32 (3) · 277-284
DOI: 10.1037/pha0000682 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Experimental and Clinical Psychopharmacology, 2024-06. Verfasst von Marcel O Bonn-Miller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Canopy Growth Corporation. Hauptthemen laut MEDLINE: Sleep Quality, Cannabidiol. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Gefördert von: Canopy Growth Corporation.
Themen: Schlaf
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Canopy Growth Corporation.
- Wana Brands.
Förderung
- Canopy Growth Corporation
Zitieren
APA
Bonn-Miller, M. O., Feldner, M. T., Bynion, T. M., Eglit, G. M. L., Brunstetter, M., Kalaba, M., Zvorsky, I., Peters, E. N., & Hennesy, M. (2024). A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Experimental and Clinical Psychopharmacology, 32(3), 277-284. https://doi.org/10.1037/pha0000682
Vancouver
Bonn-Miller MO, Feldner MT, Bynion TM, Eglit GML, Brunstetter M, Kalaba M, et al. A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality. Experimental and Clinical Psychopharmacology. 2024;32(3):277-284. doi:10.1037/pha0000682
BibTeX
@article{BonnMiller2024,
author = {Bonn-Miller, Marcel O and Feldner, Matthew T and Bynion, Teah M and Eglit, Graham M L and Brunstetter, Megan and Kalaba, Maja and Zvorsky, Ivori and Peters, Erica N and Hennesy, Mike},
title = {A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality},
journal = {Experimental and Clinical Psychopharmacology},
year = {2024},
volume = {32},
number = {3},
pages = {277--284},
doi = {10.1037/pha0000682}
}
EUVIMED